Page last updated: 2024-08-23

etoposide and Cancer of Head

etoposide has been researched along with Cancer of Head in 69 studies

Research

Studies (69)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (21.74)	18.7374
1990's	22 (31.88)	18.2507
2000's	19 (27.54)	29.6817
2010's	12 (17.39)	24.3611
2020's	1 (1.45)	2.80

Authors

Authors	Studies
Crowe, DL; Wu, J	1
Bardet, E; Bompas, E; Bourhis, J; Daly-Schveitzer, N; Lusinchi, A; Rolland, F; Rosine, D; Tao, Y	1
Brasch, F; Gehl, HB; Görner, M; Hirnle, P; Scholtz, LU; Sudhoff, H; Wegehenkel, K	1
Bigenzahn, J; Brunner, M; Heiduschka, G; Thurnher, D	1
Komune, S; Nakashima, T; Toh, S; Yamauchi, M; Yasumatsu, R	1
Aguiar, Sdos S; Almeida, MT; Barreto, JH; Bruniera, P; D'Andrea, ML; de Oliveira, CZ; Lima, ER; Lopes, LF; Lopes, PM; Macedo, CR; Martins, GE; Melaragno, R; Milone, M; Moreira, ME; Pianovski, MA; Sonaglio, V; Vianna, SM; Watanabe, FM	1
Avitia, S; Hamilton, JS; Osborne, RF	1
Dimitrova, DD; Glanzer, JG; Manthey, KC; Oakley, GG	1
He, J; Song, Y; Wang, JW; Wang, LH; Wu, LY	1
Chang, I; Chen, Z; Kang, M; Song, J; Wang, CY	1
Chang, PM; Chang, SY; Chen, MH; Chu, PY; Huang, YC; Tzeng, CH; Yang, MH	1
Ikeda, MA; Liu, J; Tsuchida, N; Uematsu, H	1
Borca, VC; Cante, D; Canzi, P; Carassai, P; Catuzzo, P; Ceroni, P; Franco, P; Girelli, G; La Porta, MR; Migliaccio, F; Numico, G; Ozzello, F; Pasquino, M; Ricardi, U; Sciacero, P; Tofani, S	1
Escobar, H; Folkens, JU; Hoffmann, R; Kontny, U; Pohl, M; van Buiren, M; Wild, D; Yoshimi, A	1
Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K	1
Akaeda, T; Hori, K; Isaka, K; Itoh, H; Nagata, J; Suzuki, Y; Takayama, M; Yudate, T	1
Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB	1
Dou, QP; Kuhn, DJ; Pross, S; Smith, DM; Whiteside, TL	1
Hanazono, Y; Ichimura, K; Kanazawa, T; Kitamura, K; Kume, A; Mizukami, H; Nishino, H; Okada, T; Ozawa, K	1
Hulsbergen-van de Kaa, CA; Oyen, WJ; Spermon, JR; Strijk, SP; Witjes, JA	1
Aimé, P; Coninx, P; Legros, M; Mérol, JC; Moutel, K; Nasca, S; Prévost, A; Roger-Liautaud, F	1
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D	1
Bagatell, R; Bowman, LC; Brodeur, GM; Castleberry, R; Cohn, SL; Frantz, C; Joshi, V; London, WB; Look, AT; Rao, PV; Rumcheva, P; Thorner, P	1
King, MM; Osswald, MB	1
Arvind, R; Kaneda, Y; Matsumura, K; Omura, K; Sakai, E; Shimamoto, H; Tsuchida, N; Zhang, S	1
Atarashi, Y; Sato, TA; Stanson, J; Whiteside, TL; Wieckowski, E	1
Bourguignon, LY; Peyrollier, K; Wang, SJ	1
Cho, YH; Hah, JH; Heo, DS; Kim, DW; Kim, KH; Lee, SH; Rhee, CS; Sung, MW; Wu, HG	1
Jungi, WF	1
Bowman, CA; Fetherstonhaugh, EM; Gelmon, K; Karsai, H; Knowling, MA; Mclaughlin, MJ; Murray, N; Osoba, D; Page, R; Shah, A	1
Ben-Dayan, D; Djaldetti, M; Floru, S; Mittelman, M	1
Ichikawa, G; Inuyama, Y; Kawaida, M; Kohno, N; Ohnuma, T; Shirasaka, T	1
Creagan, ET; Richardson, RL; Schaid, DJ; Schutt, AJ	1
Holden, SA; Northey, D; Robinson, MF; Rosowsky, A; Teicher, BA	1
Mai, KT; Stewart, DA; Stewart, DJ	1
Burgess, R; Dawson, D; Haller, J	1
Akagi, S; Kawakami, T; Koide, I; Masuda, Y; Ogawa, A; Ogawara, T; Takiguchi, S; Tamura, S; Watanabe, S	1
Allen, GC; Devore, RF; Lubas, S; Wax, MK	1
Basu, A; Saijo, N; Weixel, K	1
Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P	1
Kalgutkar, A; Kulkarni, BK; Oak, SN; Upadhyaya, M	1
Brockstein, BE; Haraf, DJ; Humerickhouse, R; Vokes, EE	1
Arndt, CA; Miser, JS; Moertel, CL; Nascimento, AG; Neglia, JP; Schomberg, PJ; Schroeder, G; Sencer, SF; Silberman, TL; Tillisch, JK	1
Hennequin, C; Maylin, C	1
Bauman, NM; Callaghan, EJ; McCulloch, TM; Victoria, L	1
Anderson, JR; Baker, KS; Breneman, JC; Crist, WM; Grier, HE; Link, MP; Maurer, HM; Qualman, SJ; Wiener, ES	1
Cherrington, JM; Kabbinavar, F; Mann, E; Schwartz, DP; Shawver, LK; Slamon, DJ; Strawn, LM	1
Ikari, T; Kano, S; Kawaida, M; Kawaura, M; Kohno, N; Nakamizo, M; Tanaka, K	1
Gastman, BR; Johnson, DE; Rabinowich, H; Wang, GQ; Watkins, SC; Wieckowski, E; Yin, XM	1
Furukawa, S; Inoue, T; Ito, K; Kokatsu, T; Mochimatsu, I; Sawaki, S; Tsukuda, M; Watanabe, S	1
Band, PR; Connors, JM; Fetherstonhaugh, EM; Goldie, JH; Knowling, MA; Osoba, D	1
Cobarro, J; Cuchi, A; Olmo, A; Traserra, J	1
Coninx, P; Desoize, B; Legros, M; Woirin, V	1
Gradishar, WJ; Kies, MS; Vokes, EE	1
Coninx, P; Legros, M; Nguyen, TD; Panis, X	1
Daly, PA; Finn, T; Lawlor, E; O'Briain, DS; O'Brien, AA; Rogers, FM; Ward, R	1
Caliceti, U; Guaraldi, M; Martoni, A; Occhiuzzi, L; Pannuti, F; Romagnoli, D; Rossi, AP	1
Chan, D; Glisson, BS; Hong, WK; Kim, HK; Sacks, PG; Silberman, L; Zwelling, LA	1
Braun, ID; Kennedy, KA; Lazo, JS; Meandzija, B; Pham, ET; Smaldone, LF	1
Carlson, LS; Osguthorpe, JD; Stuart, R	1
Glanz, H; Görg, C; Görg, K; Havemann, K; Kleinsasser, O; Pflüger, KH	1
Gallurt Moreira, P; Millan Nuñez-Cortes, J; Senra Varela, A	1
Löhr, G; Musil, J; Nagel, GA; Rauschning, W; Schröder, M; Schuff-Werner, P	1
Atkins, JN; Capizzi, RL; Caponera, ME; Craig, JB; Jackson, DV; Muss, HB; Powell, BL; Richards, F; White, DR; Zekan, PJ	1
Bertetto, O; Calciati, A; Clerico, M; Dongiovanni, V	1
Cattan, A; Coninx, P; Garbe, E; Jezekova, D; Legros, M; Marechal, F; Nasca, S	1
Applebaum, EL; Cobleigh, MA; Hill, JH; Lad, TE; Shevrin, DE	1
Barzan, L; Carbone, A; Caruso, G; Comoretto, R; Crivellari, D; Grigoletto, E; Magri, MD; Tirelli, U; Veronesi, A	1
Felman, IE; Gala, KV; Grunberg, SM; Johnson, KB; Owens, JC	1

Reviews

6 review(s) available for etoposide and Cancer of Head

Article	Year
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas. International journal of radiation oncology, biology, physics, 2003, Apr-01, Volume: 55, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine	2003
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma. Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy	2005
Transverse nail ridgings (Beau's lines) induced by chemotherapy. Acta haematologica, 1994, Volume: 91, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nails; Prednisone; Vincristine	1994
Oral 5-FU alternatives for the treatment of head and neck cancer. Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:10 Suppl 7 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Neoplasm Recurrence, Local; Tegafur; Uracil	1998
[Continuous radiosensitizing chemotherapy]. Pathologie-biologie, 1999, Volume: 47, Issue:3 Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Nutritional Support; Radiation-Sensitizing Agents; Rectal Neoplasms	1999
Malignant triton tumor of the head and neck: A case report and review of the literature. Head & neck, 1999, Volume: 21, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatal Outcome; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Lung Neoplasms; Magnetic Resonance Imaging; Mesna; Neoplasm Recurrence, Local; Neurilemmoma; Radiotherapy Dosage; Vincristine	1999

Trials

12 trial(s) available for etoposide and Cancer of Head

Article	Year
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004-02. Radiation oncology (London, England), 2013, Feb-27, Volume: 8 Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose Fractionation, Radiation; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis	2013
A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Research Design; Risk Factors; Taiwan; Treatment Outcome	2011
A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck. Oncology reports, 2005, Volume: 14, Issue:3 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Survival Analysis; Treatment Outcome; Vomiting	2005
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-01, Volume: 23, Issue:34 Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Male; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Neutropenia; Nuclear Proteins; Oncogene Proteins; Ploidies; Prognosis; Risk Factors; Treatment Outcome	2005
Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy. Oncology (Williston Park, N.Y.), 1994, Volume: 8, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Mitomycins; Vincristine; Weight Loss	1994
Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Salvage Therapy; Vomiting	1995
Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasms. American journal of clinical oncology, 1993, Volume: 16, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Remission Induction	1993
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast. Oncology, 1997, Volume: 54 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil	1997
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Rhabdomyosarcoma, Embryonal; Risk Factors; Vincristine	2000
Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck. Japanese journal of clinical oncology, 2000, Volume: 30, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Survival Analysis	2000
[Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie, 1987, Volume: 10, Issue:3 Suppl Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunotherapy; Longitudinal Studies; Lymphocytes; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Thymus Extracts	1987
[Sequential trials in initial chemotherapy of advanced tumors of the upper aero-digestive system. Cis-diamminedichloroplatinum (DDP) versus DDP-etoposide (VP16)]. Bulletin du cancer, 1986, Volume: 73, Issue:1 Topics: Cisplatin; Drug Administration Schedule; Etoposide; Head and Neck Neoplasms; Humans; Male	1986

Other Studies

51 other study(ies) available for etoposide and Cancer of Head

Article	Year
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo. Molecular carcinogenesis, 2022, Volume: 61, Issue:1 Topics: Animals; Carcinogens; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA End-Joining Repair; Down-Regulation; Etoposide; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds, 3-Ring; Humans; Loss of Function Mutation; Mice; Neoplasm Invasiveness; Squamous Cell Carcinoma of Head and Neck; Tankyrases	2022
Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience. European journal of cancer care, 2013, Volume: 22, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2013
Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines. Acta oto-laryngologica, 2014, Volume: 134, Issue:10 Topics: Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Reference Values; Resveratrol; Squamous Cell Carcinoma of Head and Neck; Stilbenes	2014
Extrapulmonary small cell carcinoma in head and neck. The Journal of laryngology and otology, 2015, Volume: 129 Suppl 2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Drug Combinations; Etoposide; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Radiotherapy, Adjuvant; Survival Rate; Tegafur	2015
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Feb-20, Volume: 34, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Retroperitoneal Neoplasms; Risk Assessment; Survival Rate; Testicular Neoplasms; Vaginal Neoplasms; Vinblastine	2016
Lymphoma in the Waldeyer ring: a great masquerader. Ear, nose, & throat journal, 2009, Volume: 88, Issue:6 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Endoscopy; Etoposide; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Rituximab; Tonsillar Neoplasms; Treatment Outcome; Vincristine	2009
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines. Head & neck, 2010, Volume: 32, Issue:5 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Head and Neck Neoplasms; Humans; Phosphorylation; Replication Protein A	2010
[Treatment and prognosis of extrapulmonary small cell carcinoma of 243 cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy, High-Energy; Survival Rate; Urogenital Neoplasms; Young Adult	2010
Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PloS one, 2010, Jul-06, Volume: 5, Issue:7 Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; beta Catenin; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Etoposide; Flow Cytometry; Head and Neck Neoplasms; Humans; Neoplasm Proteins; Pyrazines; Signal Transduction; Stem Cells; Wnt Proteins	2010
Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Molecular cancer, 2011, Jul-31, Volume: 10 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 8; Cell Line, Tumor; DNA-Binding Proteins; Drug Evaluation, Preclinical; Enzyme Activation; Etoposide; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mitochondria; Nuclear Proteins; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Transfection; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2011
Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways. Radiation oncology (London, England), 2012, Feb-15, Volume: 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cisplatin; Cranial Irradiation; Etoposide; Head and Neck Neoplasms; Hippocampus; Humans; Induction Chemotherapy; Male; Middle Aged; Organ Sparing Treatments; Remission Induction; Respiratory Tract Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2012
Nephrotic syndrome leading to the diagnosis of classical Hodgkin's lymphoma in a 13-year-old girl. Klinische Padiatrie, 2012, Volume: 224, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Multimodal Imaging; Neoplasm Staging; Nephrotic Syndrome; Positron-Emission Tomography; Prednisone; Tomography, X-Ray Computed; Vincristine	2012
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation. Pediatric hematology and oncology, 2003, Volume: 20, Issue:2 Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine	2003
Dysgerminoma in a patient with a tumor of the neck. Empiric treatment of stage IV dysgerminoma. Gynecologic and obstetric investigation, 2002, Volume: 54, Issue:2 Topics: Adult; Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Dysgerminoma; Etoposide; Female; Head and Neck Neoplasms; Humans; Neoplasm Staging; Peplomycin; Radionuclide Imaging; Tomography, X-Ray Computed	2002
Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. Journal of cellular biochemistry, 2003, Jul-01, Volume: 89, Issue:4 Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Line, Transformed; Cyclin-Dependent Kinases; Cyclins; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Head and Neck Neoplasms; Humans; Interleukin-2 Receptor alpha Subunit; Janus Kinase 3; Multienzyme Complexes; Paclitaxel; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Receptors, Interleukin; Tumor Cells, Cultured; Ubiquitin	2003
Topoisomerase inhibitors enhance the cytocidal effect of AAV-HSVtk/ganciclovir on head and neck cancer cells. International journal of oncology, 2004, Volume: 25, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Dependovirus; Enzyme Inhibitors; Etoposide; Ganciclovir; Gene Expression; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Head and Neck Neoplasms; Humans; Thymidine Kinase; Topoisomerase I Inhibitors	2004
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis. Urology, 2004, Volume: 64, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Etoposide; Head and Neck Neoplasms; Hematoma; Humans; Male; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Scalp; Seminoma; Skin Neoplasms; Skull Neoplasms; Soft Tissue Neoplasms; Testicular Neoplasms	2004
Adjuvant chemotherapy for Merkel cell carcinoma. American journal of clinical oncology, 2005, Volume: 28, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Extremities; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Reoperation; Skin Neoplasms; Treatment Outcome	2005
Role of caspase 8 as a determinant in chemosensitivity of p53-mutated head and neck squamous cell carcinoma cell lines. Journal of medical and dental sciences, 2006, Volume: 53, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Caspase 8; Caspases; Cell Line, Tumor; Chromones; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Membrane Glycoproteins; Morpholines; Mutation; Phosphorylation; Proto-Oncogene Proteins c-akt; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53	2006
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis. Journal of cellular biochemistry, 2007, Jan-01, Volume: 100, Issue:1 Topics: Antibodies; Apoptosis; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Survival; Cyclohexylamines; Etoposide; fas Receptor; Head and Neck Neoplasms; Humans; NF-kappa B; Protein Phosphatase 1; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Staurosporine; Up-Regulation; Vanadates	2007
The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Archives of otolaryngology--head & neck surgery, 2007, Volume: 133, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Topoisomerases, Type II; Etoposide; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Hyaluronic Acid; Male; Phosphorylation; Signal Transduction; Type C Phospholipases	2007
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer. Head & neck, 2008, Volume: 30, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Vincristine	2008
Etoposide single-agent chemotherapy for solid tumors. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Carcinoma, Hepatocellular; Etoposide; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Sarcoma; Soft Tissue Neoplasms	1982
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Etoposide; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Mice; Mice, Inbred C3H; Novobiocin; Ornithine; Pterins; Topoisomerase II Inhibitors; Trimetrexate; Tumor Cells, Cultured	1995
Active chemotherapy for metastatic stromal cell tumor of the testis. Urology, 1993, Volume: 42, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Sex Cord-Gonadal Stromal Tumors; Testicular Neoplasms	1993
Increased cytotoxicity of squamous cell carcinoma of the head and neck by combining cisplatin with VP-16 and ciprofloxacin. The Laryngoscope, 1993, Volume: 103, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Survival; Ciprofloxacin; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Head and Neck Neoplasms; Humans; Tumor Cells, Cultured	1993
[Etoposide, pirarubicin and cisplatin(ETP) combined therapy of inoperable head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged	1993
Epidermal growth factor regulates topoisomerase II activity and drug sensitivity in human KB cells. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1996, Volume: 114, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Catalysis; Cell Division; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Etoposide; Head and Neck Neoplasms; Humans; KB Cells; Tumor Cells, Cultured	1996
Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:11 Topics: Antineoplastic Agents; Bleomycin; Bryostatins; Carcinoma; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Head and Neck Neoplasms; Herpes Simplex Virus Protein Vmw65; Humans; Lactones; Lung Neoplasms; Macrolides; Ovarian Neoplasms; Paclitaxel; Phorbol 12,13-Dibutyrate; Protein Kinase C; Signal Transduction; Tumor Cells, Cultured	1996
Nonmidline yolk sac tumour of the head and neck region in an infant with Dandy Walker syndrome--case report and review of literature. Indian journal of cancer, 1997, Volume: 34, Issue:4 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dandy-Walker Syndrome; Endodermal Sinus Tumor; Etoposide; Female; Head and Neck Neoplasms; Humans; India; Infant; Tomography, X-Ray Computed; Treatment Outcome	1997
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Meningeal Neoplasms; Pilot Projects; Rhabdomyosarcoma; Risk Factors; Sarcoma; Urogenital Neoplasms; Vincristine	1998
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:7 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Division; Cell Survival; Cisplatin; Etoposide; Glioblastoma; Head and Neck Neoplasms; Humans; Isoxazoles; Leflunomide; Lung Neoplasms; Mice; Mice, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2000
Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade. Cancer research, 2000, Dec-15, Volume: 60, Issue:24 Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Bongkrekic Acid; Carbocyanines; Carcinoma, Squamous Cell; Carrier Proteins; Caspase 9; Caspases; Coculture Techniques; Cyclosporine; Cytochrome c Group; Cytosol; DNA; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Fluorescent Antibody Technique; Fluorescent Dyes; Head and Neck Neoplasms; Humans; Jurkat Cells; Lymphocytes; Microscopy, Fluorescence; Mitochondria; Oligopeptides; Protein Transport; Subcellular Fractions; T-Lymphocytes; Tumor Cells, Cultured	2000
[Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Peplomycin; Tumor Cells, Cultured; Vincristine	1992
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin. Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 5 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Survival Rate	1992
[Cervical seminoma. Presentation of a case]. Anales otorrinolaringologicos ibero-americanos, 1991, Volume: 18, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dysgerminoma; Etoposide; Head and Neck Neoplasms; Humans; Incidence; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Organoplatinum Compounds; Superior Vena Cava Syndrome; Testicular Neoplasms	1991
Reduced oral etoposide bioavailability in patients with advanced cancer of the head and neck. Journal of the National Cancer Institute, 1992, Mar-04, Volume: 84, Issue:5 Topics: Administration, Oral; Adult; Aged; Alcoholism; Biological Availability; Carcinoma, Squamous Cell; Etoposide; Head and Neck Neoplasms; Humans; Injections, Intravenous; Middle Aged	1992
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer. Medical and pediatric oncology, 1990, Volume: 18, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Inflammation; Leukocyte Count; Leukopenia; Mucous Membrane; Platelet Count; Remission Induction; Thrombocytopenia	1990
Relation between responses to induction chemotherapy and subsequent radiotherapy in advanced or multicentric squamous cell carcinomas of the head and neck. International journal of radiation oncology, biology, physics, 1990, Volume: 18, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged	1990
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia. Cancer, 1987, Oct-01, Volume: 60, Issue:7 Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Histocytochemistry; HLA-DR Antigens; Humans; Leukemia, Hairy Cell; Lymphatic Metastasis; Lymphoma; Microscopy, Electron; Middle Aged; Prednisone; Procarbazine; Scalp; T-Lymphocytes; Vincristine	1987
Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Pilot Projects	1988
Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line. Cancer research, 1989, Mar-01, Volume: 49, Issue:5 Topics: Amsacrine; Carcinoma, Squamous Cell; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Etoposide; Head and Neck Neoplasms; Humans; Tretinoin; Tumor Cells, Cultured	1989
Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells. Cancer research, 1985, Volume: 45, Issue:5 Topics: Animals; Bleomycin; Calmodulin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; DNA Repair; Drug Synergism; Etoposide; Head and Neck Neoplasms; Humans; Leukemia L1210; Lidocaine; Mice	1985
Multimodality treatment of advanced head and neck carcinoma. Journal of the South Carolina Medical Association (1975), 1989, Volume: 85, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Pilot Projects	1989
[Therapy of adenoid cystic carcinoma with cisplatin, etoposide and vindesine]. Onkologie, 1988, Volume: 11, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Vindesine	1988
A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck. Oncology, 1988, Volume: 45, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local	1988
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies. Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cytarabine; Drug Evaluation; Etoposide; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged	1987
Phase II trial of VP16-213 in squamous cell carcinoma of the head and neck. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged	1987
Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck. Cancer treatment reports, 1987, Volume: 71, Issue:3 Topics: Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Neoplasm Staging	1987
Phase II trial of oral VP 16-213 (etoposide) in patients with advanced head and neck cancer. Tumori, 1985, Oct-31, Volume: 71, Issue:5 Topics: Aged; Drug Evaluation; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Podophyllotoxin	1985
Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Alopecia; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Leukopenia; Lymphatic Metastasis; Podophyllotoxin	1985